Adaptive radiation therapy before surgery for soft-tissue sarcoma
Part of Cancer clinical trials.
This trial tests a personalized (“adaptive”) radiation plan before surgery for high-grade soft-tissue sarcoma that can be removed. It may help shrink the tumor and improve how well surgery can treat the cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You can sign consent and are willing to follow the study plan for the full time needed
- You have high-grade (grade 2 or 3) soft-tissue sarcoma in the deep body or arm/leg area
- Your cancer is resectable by surgery and has not spread to distant organs (T1–4, N0, M0)
- You have measurable tumor visible at the main site, plus an MRI within 4 weeks before radiation starts
- You can get an MRI (no MRI contraindications) and you cannot be pregnant
- You must agree to blood/plasma samples for future research and follow required lifestyle rules
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adding immunotherapy drugs (anlotinib and penpulimab) to radiation before surgery can help treat soft tissue sarcoma—a type of cancer in muscles, fat, or connective tissue. The goal is to shrink the tumor and improve surgical outcomes.
This trial tests if giving a short course of radiation therapy combined with immunotherapy before surgery can improve outcomes for people with soft tissue sarcoma in the belly or pelvis. It is for patients whose tumors are hard to remove completely without this pre-treatment.
This trial tests a precision medicine approach by giving targeted therapy before surgery for high-risk soft tissue sarcoma. The goal is to see if matching treatment to your tumor's type can improve outcomes.
This trial tests a short course of radiation before surgery to shrink a soft-tissue sarcoma and make it easier to remove. It may help by improving how well the tumor can be removed, while studying safety and effectiveness for this cancer type.
This trial tests a new approach for high-risk soft tissue sarcoma of the arm, leg, or trunk. Before surgery, you would receive chemotherapy combined with local hyperthermia (a treatment that gently heats the tumor area) to see if this can improve outcomes.
This trial tests whether a shorter course of radiation before surgery is effective for soft tissue sarcomas in certain locations. It aims to make treatment more convenient while maintaining good results.
Hear when a new High Grade Sarcoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.